On March 18, 2024, Ira Duarte was designated as Heron Therapeutics, Inc.'s principal accounting officer, replacing Lisa Peraza, the Company's current Chief Accounting Officer and principal accounting officer, effective March 29, 2024 (the Effective Date). Ms. Peraza will continue to serve in her current position until her employment with the Company ends on the Effective Date.